Healthcare -
Biotechnology - NASDAQ - US
$ 3.62
-3.21 %
$ 124 M
Market Cap
-1.37
P/E
TARA - COST OF REVENUE
Cost of Revenue TARA - Protara Therapeutics, Inc.
341 K
LAST VALUE
-45.94%
2 YEAR CAGR
24.28%
5 YEAR CAGR
28.87%
10 YEAR CAGR